In this application we propose to utilize next-generation sequencing combined with high-efficiency genomic sequence capture to systematically fine-map the 14q31 region which, based on the currently available data, very likely contains an important AD susceptibility locus(i). Newly identified variants will be followed up in more than 5,500 DNAs from both family-based and case-control backgrounds.
Fine Mapping of Prioritized GWAS Results
Funding to date:
© 2005-2017 Cure Alzheimer's Fund. All rights reserved.